Autolus Therapeutics plc (FRA:6A3A)
Germany · Delayed Price · Currency is EUR 1.180
+0.050 (4.42%)
At close: Mar 27, 2026
Autolus Therapeutics Revenue
In the year 2025, Autolus Therapeutics had annual revenue of $75.39M USD with 644.94% growth. Autolus Therapeutics had revenue of $24.29M in the quarter ending December 31, 2025, with 83,655.17% growth.
Revenue
$75.39M
Revenue Growth
+644.94%
P/S Ratio
4.35
Revenue / Employee
$116.16K
Employees
649
Market Cap
279.52M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 75.39M | 65.27M | 644.94% |
| Dec 31, 2024 | 10.12M | 8.42M | 496.00% |
| Dec 31, 2023 | 1.70M | -4.66M | -73.30% |
| Dec 31, 2022 | 6.36M | 4.03M | 172.96% |
| Dec 31, 2021 | 2.33M | 615.00K | 35.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biotest Aktiengesellschaft | 635.20M |
| 2invest AG | 28.07M |
| Darwin AG | 27.35M |
| Paion AG | 14.81M |
| co.don AG | 6.24M |
| MagForce AG | 1.08M |
| Biomark Diagnostics | 57.01K |
| bioXXmed AG | 20.49K |